Spectral Medical, Inc. (EDT.TO)
1.35
0.00 (0.00%)
CAD |
TSX |
Aug 25, 15:56
Spectral Medical Enterprise Value : 420.22M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 420.22M |
| August 21, 2026 | 417.29M |
| August 20, 2026 | 414.35M |
| August 19, 2026 | 408.48M |
| August 18, 2026 | 437.84M |
| August 17, 2026 | 434.90M |
| August 14, 2026 | 429.03M |
| August 13, 2026 | 437.84M |
| August 12, 2026 | 431.97M |
| August 11, 2026 | 431.97M |
| August 10, 2026 | 431.97M |
| August 07, 2026 | 437.84M |
| August 06, 2026 | 434.90M |
| August 05, 2026 | 434.90M |
| August 04, 2026 | 437.84M |
| July 31, 2026 | 431.97M |
| July 30, 2026 | 434.90M |
| July 29, 2026 | 431.97M |
| July 28, 2026 | 426.10M |
| July 27, 2026 | 429.03M |
| July 24, 2026 | 420.22M |
| July 23, 2026 | 429.03M |
| July 21, 2026 | 434.90M |
| July 20, 2026 | 434.90M |
| July 17, 2026 | 440.77M |
| Date | Value |
|---|---|
| July 16, 2026 | 426.10M |
| July 15, 2026 | 420.22M |
| July 14, 2026 | 423.16M |
| July 13, 2026 | 414.35M |
| July 10, 2026 | 420.22M |
| July 09, 2026 | 417.29M |
| July 08, 2026 | 417.29M |
| July 07, 2026 | 414.35M |
| July 06, 2026 | 423.16M |
| July 03, 2026 | 414.35M |
| July 02, 2026 | 417.29M |
| June 30, 2026 | 411.42M |
| June 29, 2026 | 407.66M |
| June 26, 2026 | 419.40M |
| June 25, 2026 | 416.47M |
| June 24, 2026 | 416.47M |
| June 23, 2026 | 419.40M |
| June 22, 2026 | 419.40M |
| June 19, 2026 | 419.40M |
| June 18, 2026 | 419.40M |
| June 17, 2026 | 425.27M |
| June 16, 2026 | 425.27M |
| June 15, 2026 | 428.20M |
| June 12, 2026 | 425.27M |
| June 11, 2026 | 422.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Resverlogix Corp. | 142.86M |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | 2.971M |
| Restart Life Sciences Corp. | 3.313M |
| Defence Therapeutics Inc | 36.41M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.331M |
| Revenue (Quarterly) | 0.621M |
| Total Expenses (Quarterly) | 0.29M |
| EPS Diluted (Quarterly) | 0.0011 |
| Gross Profit Margin (Quarterly) | -186.3% |
| Profit Margin (Quarterly) | 53.30% |
| Earnings Yield | -9.20% |
| Normalized Earnings Yield | -5.756 |